Parkinson's drug solengepras to be filed for approval after trial reports daily-living gains
Patients in the ARISE trial reported improvements in daily living and gained an average of 36 more minutes of "good"…
Asia Tech Times — Technology, science and culture across Asia
Health technology, medicine and wellbeing. Asia Tech Times covers diagnostics, digital health, medtech and the science behind them in Asia's hospitals and labs.
63 stories Page 3 of 6
Patients in the ARISE trial reported improvements in daily living and gained an average of 36 more minutes of "good"…
Celltrion USA said the oral presentations cover subcutaneous versus intravenous infliximab in ileum-dominant Crohn's…
The company points to two separately conducted reader studies that reported lower mean review times for AI-assisted…
Shenzhen Ninenovo says its RingConn smart ring has cleared US regulatory review for non-invasive SpO2 measurement.
The company reported that its once-daily PDE4B inhibitor outperformed apremilast at Week 16 and is now being taken into…
The company said Europe's biologics market is projected to reach about US$269.65 billion by 2035 and pointed to its…
Ono takes rights to BHV-1300 and two follow-on degraders in Japan, South Korea, Taiwan and ASEAN, with up to $100…
Andor Health said its ambient documentation tool is now listed in Epic Toolbox for Ambient Voice Recognition: Nursing…
The collaboration aims to widen access to cystic fibrosis monitoring in the Middle East and other underserved regions…
The two companies said CSL will make a US$355 million initial payment, with up to US$1.2 billion more in commercial…
The companies presented feasibility study findings at EASD 2026 for an investigational wearable patch that combines…
Three boys in a Phase I dose-escalation trial showed utrophin increases in paired muscle biopsies, with the company…